FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980348913> ?p ?o ?g. }

• W2980348913 endingPage "942" @default.
• W2980348913 startingPage "938" @default.
• W2980348913 abstract "The Journal of Molecular Diagnostics (JMD)—the official journal of the Association for Molecular Pathology (AMP) and co-owned by the American Society for Investigative Pathology (ASIP)—has been a key component for communicating among our practitioners and other medical disciplines. The AMP has provided a forum for experts to share ideas and insights by supporting workshops at the annual meetings and coordinating focused workgroups to develop expert, consensus, and evidence-based guidelines and recommendations for best laboratory practices. The JMD has served as the preferred platform to disseminate these collective principles through peer-reviewed publications to AMP members and the broader clinical laboratory community. From November 1999 to August 2019, the JMD has published 106 issues and three supplements. These issues included hundreds of assay validation studies which have been highly valued examples of implementation of new techniques and methods in clinical diagnostic laboratories. Demonstrations of assay validity have provided examples for the practical application of techniques and methods as well as roadmaps to fulfill guidelines and develop standards. Quality measures for regulatory compliance are also featured in many of these studies, illustrating the increased requirements for professional expertise inherent in clinical laboratory operations. Most assay validations incorporate accepted technology comparisons to introduce newer approaches and quality improvements as well as the limitations of various methods that have been in use. The JMD has also published studies that broaden our understanding of test performance in specific patient populations or ethnic groups, focusing not only on international studies but clinical centers within the US that serve immigrant populations. Dozens of multi-center and multi-laboratory comparison studies1McGinniss M.J. Chen R. Pratt V.M. Buller A. Quan F. Strom C.M. Sun W. Crossley B. Development of a web-based query tool for quality assurance of clinical Molecular genetic test results.J Mol Diagn. 2007; 9: 95-98Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar, 2Johnson M.A. Yoshitomi M.J. Richards C.S. A comparative study of five technologically diverse CFTR testing platforms.J Mol Diagn. 2007; 9: 401-407Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar, 3Riley J.D. Procop G.W. Kottke-Marchant K. Wyllie R. Lacbawan F.L. Improving molecular genetic test utilization through order restriction, test review, and guidance.J Mol Diagn. 2015; 17: 225-229Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar, 4Emmert-Buck M.R. Strausberg R.L. Krizman D.B. Bonaldo M.F. Bonner R.F. Bostwick D.G. Brown M.R. Buetow K.H. Chuaqui R.F. Cole K.A. Duray P.H. Englert C.R. Gillespie J.W. Greenhut S. Grouse L. Hillier L.W. Katz K.S. Klausner R.D. Kuznetzov V. Lash A.E. Lennon G. Linehan W.M. Liotta L.A. Marra M.A. Munson P.J. Ornstein D.K. Prabhu V.V. Prange C. Schuler G.D. Soares M.B. Tolstoshev C.M. Vocke C.D. Waterston R.H. Molecular profiling of clinical tissue specimens.J Mol Diagn. 2000; 2: 60-66Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar, 5Ledford M. Friedman K.D. Hessner M.J. Moehlenkamp C. Williams T.M. Larson R.S. A multi-site study for detection of factor V (leiden) mutation from genomic DNA using a homogeneous invader microtiter plate fluorescence resonance energy transfer (FRET) assay.J Mol Diagn. 2000; 2: 97-104Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar, 6Arber D.A. Braziel R.M. Bagg A. Bijwaard K.E. Evaluation of T cell receptor testing in lymphoid neoplasms: results of a multicenter study of 29 extracted DNA and paraffin-embedded samples.J Mol Diagn. 2001; 3: 133-140Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar, 7Bagg A. Braziel R.M. Arber D.A. Bijwaard K.E. Chu A.Y. Immunoglobulin heavy chain gene analysis in lymphomas: a multi-center study demonstrating the heterogeneity of performance of polymerasec reaction assays.J Mol Diagn. 2002; 4: 81-89Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar, 8Giuffre G. ller A.M. Brodegger T. Bocker-Edmonston T. Gebert J. Kloor M. Dietmaier W. Kullmann F. Buttner R. Tuccari G. Ruschoff J. German HNPCC Consortium, German Cancer Aid (Deutsche Krebshilfe)Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection.J Mol Diagn. 2005; 7: 160-170Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar, 9Christensen T.M. Jama M. Ponek V. Lyon E. Wilson J.A. Hoffmann M.L. Bejjani B.A. Design, development, validation, and use of synthetic nucleic acid controls for diagnostic purposes and application to cystic fibrosis testing.J Mol Diagn. 2007; 9: 315-319Abstract Full Text Full Text PDF PubMed Scopus (10) Google Scholar, 10Zhang T. Grenier S. Nwachukwu B. Wei C. Lipton J.H. Kamel-Reid S. Association for Molecular Pathology Hematopathology SubdivisionInter-saboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations.J Mol Diagn. 2007; 9: 421-430Abstract Full Text Full Text PDF PubMed Scopus (49) Google Scholar, 11Dumur C.I. Lyons-Weiler M. Sciulli C. Garrett C.T. Schrijver I. Holley T.K. Rodriguez-Paris J. Pollack J.R. Zehnder J.L. Price M. Hagenkord J.M. Rigl C.T. Buturovic L.J. Anderson G.G. Monzon F.A. Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers.J Mol Diagn. 2008; 10: 67-77Abstract Full Text Full Text PDF PubMed Scopus (81) Google Scholar, 12Wolff D.J. Heaney D.L. Neuwald P.D. Stellrecht K.A. Press R.D. Multi-site PCR-based CMV viral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the Association for Molecular Pathology.J Mol Diagn. 2009; 11: 87-92Abstract Full Text Full Text PDF PubMed Scopus (44) Google Scholar, 13Pratt V.M. Caggana M. Bridges C. Buller A.M. DiAntonio L. Highsmith W.E. Holtegaard L.M. Muralidharan K. Rohlfs E.M. Tarleton J. Toji L. Barker S.D. Kalman L.V. Development of genomic reference materials for cystic fibrosis genetic testing.J Mol Diagn. 2009; 11: 186-193Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar, 14Whitehall V. Tran K. Umapathy A. Grieu F. Hewitt C. Evans T.-J. Ismail T. Li W.Q. Collins P. Ravetto P. Leggett B. Salto-Tellez M. Soong R. Fox S. Scott R.J. Dobrovic A. Iacopetta B. A multicenter blinded sudy to evaluate KRAS mutation testing methodologies in the clinical setting.J Mol Diagn. 2009; 11: 543-552Abstract Full Text Full Text PDF PubMed Scopus (113) Google Scholar, 15Xiang B. Zhu H. Shen Y. Miller D.T. Lu K. Hu X. Andersson H.C. Narumanchi T.M. Wang Y. Martinez J.E. Wu B.-L. Li P. Li M.M. Chen T.-J. Fan Y.-S. Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: a multicenter experience of 1499 clinical cases.J Mol Diagn. 2010; 12: 204-212Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar, 16Pratt V.M. Zehnbauer B. Wilson J.A. Baak R. Babic N. Bettinotti M. Buller A. Butz K. Campbell M. Civalier C. El-Badry A. Farkas D.H. Lyon E. Mandal S. McKinney J. Muralidharan K. Noll L. Sander T. Shabbeer J. Smith C. Telatar M. Toji L. Vairavan A. Vance C. Weck K.E. Wu A.H.B. Yeo K.T. Zeller M. Kalman L. Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.J Mol Diagn. 2010; 12: 835-846Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar, 17Pritchard C.C. Smith C. Salipante S.J. Lee M.K. Thornton A.M. Nord A.S. Gulden C. Kupfer S.S. Swisher E.M. Bennett R.L. Novetsky A.P. Jarvik G.P. Olopade O.I. Goodfellow P.J. King M.-C. Tait J.F. Walsh T. ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.J Mol Diagn. 2012; 14: 357-366Abstract Full Text Full Text PDF PubMed Scopus (164) Google Scholar, 18Beau-Faller M. Blons H. Domerg C. Gajda D. Richard N. Escande F. Solassol J. Denis M.G. Cayre A. Nanni-Metellus I. Olschwang S. Lizard S. Piard F. Pretet J.-L. de Fraipont F. Bièche I. de Cremoux P. Rouquette I. Bringuier P.-P. Mosser J. Legrain M. Voegeli A.-C. Saulnier P. Morin F. Pignon J.-P. Zalcman G. Cadranel J. A Multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting - IFCT/ERMETIC2 project part 1.J Mol Diagn. 2014; 16: 45-55Abstract Full Text Full Text PDF PubMed Scopus (31) Google Scholar, 19Pratt V.M. Everts R.E. Aggarwal P. Beyer B.N. Broeckel U. Epstein-Baak R. Hujsak P. Kornreich R. Liao J. Lorier R. Scott S.A. Huang Smith C. Toji L.H. Turner A. Kalman L.V. Characterization of 137 cenomic DNA reference materials for 28 pharmacogenetic genes.J Mol Diagn. 2016; 18: 109-123Abstract Full Text Full Text PDF PubMed Scopus (83) Google Scholar, 20Dequeker E.M.C. Keppens C. Egele C. Delen S. Lamy A. Lemoine A. Sabourin J.-C. Andrieu C. Ligtenberg M. Fetique D. Tops B. Descarpentries C. Blons H. Denoux Y. Aube C. Penault-Llorca F. Hofman P. Leroy K. Le Marechal C. Doucet L. Duranton-Tanneur V. Pedeutour F. Soubeyran I. Côté J.-F. Emile J.-F. Vignaud J.-M. Monhoven N. Haddad V. Laurent-Puig P. van Krieken H. Nowak F. Lonchamp E. Bellocq J.-P. Rouleau E. Three rounds of external quality assessment in France to evaluate the performance of 28 platforms for multiparametric molecular testing in metastatic colorectal and non-small cell lung cancer.J Mol Diagn. 2016; 18: 205-214Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar, 21Zhang R. Zhang H. Li Y. Han Y. Xie J. Li J. External quality assessment for detection of fetal trisomy 21, 18, and 13 by massively parallel sequencing in clinical laboratories.J Mol Diagn. 2016; 18: 244-252Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar, 22Davies K.D. Farooqi M.S. Gruidl M. Hill C.E. Woolworth-Hirschhorn J. Jones H. Jones K.L. Magliocco A. Mitui M. O'Neill P.H. O'Rourke R. Patel N.M. Qin D. Ramos E. Rossi M.R. Schneider T.M. Smith G.H. Zhang L. Park J.Y. Aisner D.L. Multi-institutional FASTQ file exchange as a means of proficiency testing for next-generation sequencing bioinformatics and variant interpretation.J Mol Diagn. 2016; 18: 572-579Abstract Full Text Full Text PDF PubMed Scopus (19) Google Scholar, 23Bettinotti M.P. Ferriola D. Duke J.L. Mosbruger T.L. Tairis N. Jennings L. Kalman L.V. Monos D. Characterization of 108 genomic DNA reference materials for 11 human leukocyte antigen loci.J Mol Diagn. 2018; 20: 703-715Abstract Full Text Full Text PDF Scopus (8) Google Scholar, 24Santani A. Simen B.B. Briggs M. Lebo M. Merker J.D. Nikiforova M. Vasalos P. Voelkerding K. Pfeifer J. Funke B. Designing and implementing NGS tests for inherited disorders. a practical framework with step-by-step guidance for clinical laboratories.J Mol Diagn. 2019; 21: 369-374Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar have been published to illustrate the collective experiences and challenges of our colleagues and peers. Many were organized and produced by AMP workgroups; others were formed by groups of laboratory directors and experts with shared needs and perspectives. These have featured contributions from academic centers, reference laboratories, and industry laboratories—reflecting the diversity of AMP members and highlighting the interconnectedness of our practice venues. At least 30 recommendations for best laboratory practices to aid molecular pathology laboratories in achieving quality operations, standardization, and regulatory compliance have been published in the JMD. In the same way that the early workshop sessions of AMP meetings provided forums for vigorous discussion and debate about the most effective molecular biology methods during the early days of our specialty, more than half of these are expert consensus guidance25White P.L. Barton R. Guiver M. Linton C.J. Wilson S. Smith M. Gomez B.L. Carr M.J. Kimmitt P.T. Seaton S. Rajakumar K. Holyoake T. Kibbler C.C. Johnson E. Hobson R.P. Jones B. Barnes R.A. United Kingdom fungal polymerase chain reaction consensus group. a consensus on fungal polymerase chain reaction diagnosis?.J Mol Diagn. 2006; 8: 376-384Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar, 26Wolff D.J. Bagg A. Cooley L.D. Dewald G.W. Hirsch B.A. Jacky P.B. Rao K.W. Rao P.N. Association for Molecular Pathology Clinical Practice Committee and the American College of Medical Genetics Laboratory Quality Assurance CommitteeGuidance for fluorescence in situ hybridization testing in hematologic disorders.J Mol Diagn. 2007; 9: 134-143Abstract Full Text Full Text PDF PubMed Scopus (104) Google Scholar, 27Wilson J.A. Pratt V.M. Phansalkar A. Muralidharan K. Highsmith Jr., W.E. Beck J.C. Bridgeman S. Courtney E.M. Epp L. Ferreira-Gonzalez A. Hjelm N.L. Holtegaard L.M. Jama M.A. Jakupciak J.P. Johnson M.A. Labrousse P. Lyon E. Prior T.W. Richards C.S. Richie K.L. Roa B.B. Rohlfs E.M. Sellers T. Sherman S.L. Siegrist K.A. Silverman L.M. Wiszniewska J. Kalman L.V. Fragile Xperts Working Group of the Association for Molecular Pathology Clinical Practice CommitteeConsensus characterization of 16 FMR1 reference materials: a consortium study.J Mol Diagn. 2008; 10: 2-12Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar, 28Lubin I.M. Caggana M. Constantin C. Gross S.J. Lyon E. Pagon R.A. Trotter T.L. Wilson J.A. McGovern M.M. Ordering molecular genetic tests and reporting results: practices in laboratory and clinical settings.J Mol Diagn. 2008; 10: 459-468Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar, 29Jones D. Kamel-Reid S. Bahler D. Dong H. Elenitoba-Johnson K. Press R. Quigley N. Rothberg P. Sabath D. Viswanatha D. Weck K. Zehnder J. Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology.J Mol Diagn. 2009; 11: 4-11Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar, 30Sepulveda A.R. Jones D. Ogino S. Samowitz W. Gulley M.L. Edwards R. Levenson V. Pratt V.M. Yang B. Nafa K. Yan L. Vitazka P. CpG methylation analysis—current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular Pathology.J Mol Diagn. 2009; 11: 266-278Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar, 31Muralidharan K. Wilson R.B. Ogino S. Nagan N. Curtis C. Schrijver I. Population carrier screening for spinal muscular atrophy: a position statement of the Association for Molecular Pathology.J Mol Diagn. 2011; 13: 3-6Abstract Full Text Full Text PDF PubMed Scopus (22) Google Scholar, 32Nagan N. Faulkner N.E. Curtis C. Schrijver I. Laboratory guidelines for detection, interpretation, and reporting of maternal cell contamination in prenatal analyses: a report of the Association for Molecular Pathology.J Mol Diagn. 2011; 13: 7-11Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar, 33Funkhouser Jr., W.K. Lubin I.M. Monzon F.A. Zehnbauer B.A. Evans J.P. Ogino S. Nowak J.A. Relevance, pathogenesis, and testing algorithm for mismatch repair–defective colorectal carcinomas: a report of the Association for Molecular Pathology.J Mol Diagn. 2012; 14: 91-103Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar, 34Schrijver I. Aziz N. Farkas D.H. Furtado M. Ferreira Gonzalez A. Greiner T.C. Grody W.W. Hambuch T. Lisa Kalman L. Kant J.A. Klein R.D. Leonard D.G.B. Lubin I.M. Rong Mao R. Narasimhan Nagan N. Pratt V.M. Sobel M.E. Voelkerding K.V. Gibson J.S. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology.J Mol Diagn. 2012; 14: 525-540Abstract Full Text Full Text PDF PubMed Scopus (121) Google Scholar, 35Cankovic M. Nikiforova M.N. Snuderl M. Adesina A.M. Lindeman N. Wen P.Y. Lee E.Q. The role of MGMT testing in clinical practice: a report of the Association for Molecular Pathology.J Mol Diagn. 2013; 15: 539-555Abstract Full Text Full Text PDF PubMed Scopus (51) Google Scholar, 36Gong J.Z. Cook J.R. Greiner T.C. Hedvat C. Hill C.E. Lim M.S. Longtine J.A. Sabath D. Wang Y.L. Laboratory practice guidelines for detecting and reporting JAK2 and MPL mutations in myeloproliferative neoplasms: a report of the Association for Molecular Pathology.J Mol Diagn. 2013; 15: 733-744Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar, 37Hegde M. Bale S. Bayrak-Toydemir P. Gibson J. Bone Jeng L.J. Joseph L. Laser J. Lubin I.M. Miller C.E. Ross L.F. Rothberg P.G. Tanner A.K. Vitazka P. Mao R. Reporting incidental findings in genomic scale clinical sequencing - a clinical laboratory perspective. a report of the Association for Molecular Pathology.J Mol Diagn. 2015; 17: 107-117Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar, 38Gold B. Cankovic M. Furtado L.V. Meier F. Gocke C.D. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? a report of the Association for Molecular Pathology.J Mol Diagn. 2015; 17: 209-224Abstract Full Text Full Text PDF PubMed Scopus (148) Google Scholar, 39Schrijver I. Farkas D.H. Gibson J.S. Elaine Lyon E. The AMP Executive CommitteeThe evolving role of the laboratory professional in the age of genome sequencing: a vision of the Association for Molecular Pathology.J Mol Diagn. 2015; 17: 335-338Abstract Full Text Full Text PDF PubMed Scopus (12) Google Scholar, 40Lefterova M.I. Suarez C.J. Banaei N. Pinsky B.A. Next-generation sequencing for infectious disease diagnosis and management: a report of the Association for Molecular Pathology.J Mol Diagn. 2015; 17: 623-634Abstract Full Text Full Text PDF PubMed Scopus (118) Google Scholar, 41Sabatini L.M. Mathews C. Ptak D. Doshi S. Tynan K. Hegde M.R. Burke T.L. Bossler A.D. Genomic sequencing procedure microcosting analysis and health economic cost-impact analysis: a report of the Association for Molecular Pathology.J Mol Diagn. 2016; 18: 319-328Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar, 42Joseph L. Cankovic M. Caughron S. Chandra P. Emmadi R. Hagenkord J. Hallam S. Jewell K.E. Klein R.D. Pratt V.M. Rothberg P.G. Temple-Smolkin R.L. Lyon E. The spectrum of clinical utilities in molecular pathology testing procedures for inherited conditions and cancer: a report of the Association for Molecular Pathology.J Mol Diagn. 2016; 18: 605-619Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar, 43Doern C.D. Butler-Wu S.M. Emerging and future applications of matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry in the clinical microbiology laboratory: a report of the Association for Molecular Pathology.J Mol Diagn. 2016; 18: 789-802Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar, 44Jennings L.J. Arcila M.E. Corless C. Kamel-Reid S. Lubin I.M. Pfeifer J. Temple-Smolkin R.L. Voelkerding K.V. Nikiforova M.N. Guidelines for validation of next-generation sequencing-based oncology panels. a joint consensus recommendation of the Association for Molecular Pathology and College of American Pathologists.J Mol Diagn. 2017; 19: 341-365Abstract Full Text Full Text PDF PubMed Scopus (370) Google Scholar, 45Lubin I.M. Aziz N. Babb L.J. Ballinger D. Bisht H. Church D.M. Cordes S. Eilbeck K. Hyland F. Kalman L. Landrum M. Lockhart E.R. Maglott D. Marth G. Pfeifer J.D. Rehm H.L. Roy S. Tezak Z. Truty R. Ullman-Cullere M. Voelkerding K.V. Worthey E.A. Zaranek A.W. Zook J.M. Principles and recommendations for standardizing the use of the next-generation sequencing variant file in clinical settings.J Mol Diagn. 2017; 19: 417-426Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar, 46Pratt V.M. Tredici A.L. Hachad H. Ji Y. Kalman L.V. Scott S.A. Weck K.E. Recommendations for clinical CYP2C19 genotyping allele selection. a report of the Association for Molecular Pathology.J Mol Diagn. 2018; 20: 269-276Abstract Full Text Full Text PDF PubMed Scopus (85) Google Scholar, 47Kang W. Kadri S. Puranik R. Wurst M.N. Patil S.A. Mujacic I. Benhamed S. Niu N. Zhen C.J. Ameti B. Long B.C. Galbo F. Montes D. Iracheta C. Gamboa V.L. Lopez D. Yourshaw M. Lawrence C.A. Aisner D.L. Fitzpatrick C. McNerney M.E. Wang Y.L. Andrade J. Volchenboum S.L. Furtado L.V. Ritterhouse L.L. Segal J.P. System for informatics in the molecular pathology laboratory.J Mol Diagn. 2018; 20: 522-532Abstract Full Text Full Text PDF PubMed Scopus (5) Google Scholar, 48McClure R.F. Ewalt M.D. Crow J. Temple-Smolkin R.L. Pullambhatla M. Sargent R. Kim A.S. Clinical significance of DNA variants in chronic myeloid neoplasms. a report of the Association for Molecular Pathology.J Mol Diagn. 2018; 20: 717-737Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar with workgroup insights dispersed to all readers of the JMD. In recent years, evidence-based recommendations have been produced49Betsou F. Gunter E. Clements J. DeSouza Y. Goddard K.A.B. Guadagni F. Yan W. Skubitz A. Somiari S. Yeadon T. Chuaquix R. Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group.J Mol Diagn. 2013; 15: 3-16Abstract Full Text Full Text PDF PubMed Scopus (70) Google Scholar, 50Lindeman N.I. Cagle P.T. Beasley M.B. Chitale D.A. Dacic S. Giaccone G. Jenkins R.B. Kwiatkowski D.J. Saldivar J.-S. Squire J. Thunnissen E. Ladanyi M. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors. guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.J Mol Diagn. 2013; 15: 415-453Abstract Full Text Full Text PDF PubMed Scopus (370) Google Scholar, 51Li M.M. Datto M. Duncavage E.J. Kulkarni S. Lindeman N.I. Roy S. Tsimberidou A.M. Vnencak-Jones C.L. Wolff D.J. Younes A. Nikiforova M.N. Standards and guidelines for the interpretation and reporting of sequence variants in cancer. a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.J Mol Diagn. 2017; 19: 4-23Abstract Full Text Full Text PDF PubMed Scopus (861) Google Scholar, 52Sepulveda A.R. Hamilton S.R. Allegra C.J. Grody W. Cushman-Vokoun A.M. Funkhouser W.K. Kopetz S.E. Lieu C. Lindor N.M. Minsky B.D. Monzon F.A. Sargent D.J. Singh V.M. Willis J. Clark J. Colasacco C. Rumble R.B. Temple-Smolkin R. Ventura C.B. Nowak J.A. Molecular biomarkers for the evaluation of colorectal cancer. guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.J Mol Diagn. 2017; 19: 187-225Abstract Full Text Full Text PDF PubMed Scopus (81) Google Scholar, 53Roy S. Coldren C. Karunamurthy A. Kip N.S. Klee K.W. Lincoln S.E. Leon A. Pullambhatla M. Temple-Smolkin R.L. Voelkerding K.V. Wang C. Carter A.B. Standards and guidelines for validating next-generation sequencing bioinformatics pipelines. a joint recommendation of the Association for Molecular Pathology and the College of American Pathologists.J Mol Diagn. 2018; 20: 4-27Abstract Full Text Full Text PDF PubMed Scopus (226) Google Scholar, 54Lindeman N.I. Cagle P.T. Aisner D.L. Arcila M.E. Beasley M.B. Bernicker E.H. Colasacco C. Dacic S. Hirsch F.R. Kerr K. Kwiatkowski D.J. Ladanyi M. Nowak J.A. Sholl L. Temple-Smolkin R. Solomon B. Souter L.H. Thunnissen E. Tsao M.S. Ventura C.B. Wynes M.W. Yatabe Y. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors. guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.J Mol Diagn. 2018; 20: 129-159Abstract Full Text Full Text PDF PubMed Scopus (193) Google Scholar by systematic review methods through formal collaborations between the AMP and the College of American Pathologists, the American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer, and the American College of Medical Genetics and Genomics. These multi-organizational workgroups formulated best practice recommendations which were subsequently reviewed within the governing bodies of each organization. The manuscripts were then submitted for peer-review editorial process in the JMD and frequently for co-publication in the collaborating societies' journals. Review articles55Tefferi A. Noel P. Hanson C.A. Uses and abuses of JAK2 and MPL mutation tests in myeloproliferative neoplasms.J Mol Diagn. 2011; 13: 461-466Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar, 56Tenover F.C. Baron E.J. Peterson L.R. Persing D.H. Laboratory diagnosis of clostridium difficile infection: can colecular amplification methods move us out of cncertainty?.J Mol Diagn. 2011; 13: 573-582Abstract Full Text Full Text PDF PubMed Scopus (77) Google Scholar, 57Emmadi R. Boonyaratanakornkit J.B. Selvarangan R. Shyamala V. Zimmer B.L. Williams L. Bryant B. Schutzbank T. Schoonmaker M.M. Wilson J.A.A. Hall L. Pancholi P. Bernard K. Molecular methods and platforms for infectious diseases testing.J Mol Diagn. 2011; 13: 583-604Abstract Full Text Full Text PDF PubMed Scopus (66) Google Scholar, 58Tang W. Hu Z. Muallam H. Gulley M.L. Quality assurance of RNA expression profiling in clinical laboratories.J Mol Diagn. 2012; 14: 1-11Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar, 59Murray P.R. What is new in clinical microbiology—microbial identification by MALDI-TOF mass spectrometry.J Mol Diagn. 2012; 14: 419-423Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar, 60Perrin M.J. Gollob M.H. The genetics of cardiac disease associated with sudden cardiac death.J Mol Diagn. 2012; 14: 424-436Abstract Full Text Full Text PDF PubMed Scopus (4) Google Scholar, 61Waites K.B. Xiao L. Pralanov V. Viscardi R.M. Glass J.I. Molecular methods for the detection of mycoplasma and ureaplasma infections in humans.J Mol Diagn. 2012; 14: 437-450Abstract Full Text Full Text PDF PubMed Scopus (103) Google Scholar, 62Shanmuganathan R. Basheer N.M. Amirthalingam L. Muthukumar H. Kaliaperumal R. Shanmugam K. Conventional and nanotechniques for DNA methylation profiling.J Mol Diagn. 2013; 15: 17-26Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar, 63Nybakken G.E. Bagg A. The genetic basis and expanding role of molecular analysis in the diagnosis, prognosis, and therapeutic design for myelodysplastic syndromes.J Mol Diagn. 2014; 16: 145-158Abstract Full Text Full Text PDF PubMed Scopus (27) Google Scholar, 64Gulley M.L. Morgan D.R. Molecular oncology testing in resource-limited settings.J Mol Diagn. 2014; 16: 601-611Abstract Full Text Full Text PDF Scopus (12) Google Scholar, 65Sridhar S. To K.K.W. Chan J.F.W. Lau S.K.P. Woo P.C.Y. Yuen K.-Y. A systematic approach to novel virus discovery in emerging infectious disease outbreaks.J Mol Diagn. 2015; 17: 230-241Abstract Full Text Full Text PDF PubMed Scopus (27) Google Scholar, 66Tafe L.J. Targeted next-generation sequencing for hereditary cancer syndromes.J Mol Diagn. 2015; 17: 472-482Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar, 67Lee L.A. Arvai K.J. Jones D. Annotation of sequence variants in cancer samples.J Mol Diagn. 2015; 17: 339-351Abstract Full Text Full Text PDF PubMed Scopus (8) Google Scholar, 68Rodriguez F.J. Vizcaino M.A. Lin M.-T. Recent advances on the molecular pathology of glial neoplasms in children and adults.J Mol Diagn. 2016; 18: 620-634Abstract Full Text Full Text PDF PubMed Scopus (40) Google Scholar, 69Biswas B. Clinical performance evaluation of molecular diagnostic tests.J Mol Diagn. 2016; 18: 803-812Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar, 70Wang J. Bettegowda C. Applications of DNA-based liquid biopsy for central nervous system neoplasms.J Mol Diagn. 2017; 19: 24-34Abstract Full Text Full Text PDF PubMed Scopus (44) Google Scholar, 71Leal S.M. Gulley M.L. Current and emerging molecular tests for human papillomavirus–related neoplasia in the genomic era.J Mol Diagn. 2017; 19: 366-377Abstract Full Text Full Text PDF PubMed Scopus (13) Google Scholar, 72Akgumus G. Chang F. Li M.M. Overgrowth syndromes caused by somatic variants in the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway.J Mol Diagn. 2017; 19: 487-497Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar, 73Selim A.G. Moore A.S. Molecular minimal residual disease monitoring in acute myeloid leukemia.J Mol Diagn. 2018; 20: 389-397Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar, 74Lam S.W. van IJzendoorn D.G.P. Cleton-Jansen A.-M. Szuhai K. Bovee J.V.M.G. Molecular pathology of bone tumors.J Mol Diagn. 2019; 21: 171-182Abstract Full Text Full Text PDF PubMed Scopus (15) Google Scholar, 75Carter A.B. Considerations for genomic data privacy and security when working in the cloud.J Mol Diagn. 2019; 21: 542-552Abstract Full Text Full Text PDF PubMed Scopus (25) Google Scholar, 76Hsiao S.J. Zehir A. Sireci A.N. Aisner D.L. Detection of tumor NTRK gene fusions to identify patients who may benefit from tyrosine kinase (TRK) inhibitor therapy.J Mol Diagn. 2019; 21: 553-571Abstract Full Text Full Text PDF PubMed Scopus (119) Google Scholar enable students, trainees, laboratory directors, and experts to understand the context of current diagnostic challenges and development of practical solutions. Many of the plenary sessions at the AMP annual meetings and the excellent webinars produced by the AMP Education team would make very effective review articles for the JMD. As a complement to the advocacy role that the AMP has exemplified regarding regulatory oversight and compliance for molecular diagnostics, the JMD has also published position statements, perspectives, and commentaries,77Kaul K.L. Leonard D.G.B. Gonzalez A. Garrett C.T. Oversight of genetic testing: an update.J Mol Diagn. 2001; 3: 85-91Abstract Full Text Full Text PDF PubMed Scopus (10) Google Scholar, 78Cho M.K. Illangasekare S. Weaver M.A. Leonard D.G.B. Merz J.F. Effects of patents and licenses on the provision of clinical genetic testing services.J Mol Diagn. 2003; 5: 3-8Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar, 79Mansfield E. O'Leary T.J. Gutman S.I. Food and Drug Administration regulation of in vitro diagnostic devices.J Mol Diagn. 2005; 7: 2-7Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar, 80Ferreira-Gonzalez A. Emmadi R. Day S.P. Klees R.F. Leib J.R. Lyon E. Nowak J.A. Pratt V.M. Williams M.S. Klein R.D. Revisiting oversight and regulation of molecular-based laboratory-developed tests: a position statement of the Association for Molecular Pathology.J Mol Diagn. 2014; 16: 3-6Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar, 81O'Leary T.J. Regulating laboratory-developed tests.J Mol Diagn. 2014; 16: 595-598Abstract Full Text Full Text PDF Scopus (9) Google Scholar, 82Schreier J. Feeney R. Keeling P. Diagnostics reform and harmonization of clinical laboratory testing.J Mol Diagn. 2019; 21: 737-745Abstract Full Text Full Text PDF Scopus (15) Google Scholar to inform readers and advance proposals for regulatory reform. With rapidly changing technologies, applications, and clinical utility, challenges to existing laws and regulatory guidance have added increased concerns about accreditation requirements and economic viability to the practice of clinical molecular pathology. The clinical utility of molecular pathology findings was originally recognized for discerning clinical diagnoses. Now, the support of clinical care decisions has expanded beyond initial diagnosis to include prognostic indications, carrier testing, prenatal testing, presymptomatic screening, disease predisposition, genotype-phenotype correlations, minimal residual disease detection, treatment selection, resistance to therapy, adverse drug reactions, disease risk stratification, and gene targeted therapies. The role of the molecular pathologist has also expanded beyond laboratory expert to a consulting member of the diagnostic team. Gene-targeted therapeutics require accurate and reliable detection of specific genetic signatures that will identify which patients are most likely to have a favorable response to therapy or perhaps achieve no benefit at all. In addition to the original subdivision specialties of AMP (cancer, infectious disease, and genetics), which influenced the specialty areas of JMD submissions, the Journal has grown to add pharmacogenomics and pathology informatics to reflect the changing expertise required of our practitioners. The complexity and volume of data that are now presented in the journal submissions have challenged reviewers, extended both review and revision timelines, and necessitated re-evaluation of some editorial requirements. Changes in scholarly publishing, for both print and online features, have also brought transitions in JMD communications. Open access publishing options, pre-print servers, and social media promotions through LinkedIn, Facebook, and Twitter accelerate access to accepted manuscripts. The past 20 years have also brought broader recognition of the field of molecular pathology and the importance of laboratory findings in clinical care decisions, with many more journals adding molecular diagnostics to their scope of publishing. Many medical disciplines which rely on molecular pathology laboratory data, but may not be limited to laboratory professionals, constitute new avenues to share clinical trial data, clinical utility of molecular findings, and insights for appropriate use of laboratory testing. The JMD also welcomes these topics for submissions as well as other areas that demonstrate changing demands and advantages of molecular pathology professionals' expertise in quality patient care. We also encourage submission of translational work that bridges the gap from research laboratories to clinical settings providing advance appreciation of the next trend in technology, the next biomarker associated with disease, or a new therapeutic target. As my colleagues, Karen Kaul83Kaul K.L. The Journal of Molecular Diagnostics: 20 years of education and training.J Mol Diagn. 2019; 21: 933-934Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar and Timothy O'Leary,84O'Leary T.J. The Journal of Molecular Diagnostics: 20 years of clinical innovation.J Mol Diagn. 2019; 21: 935-937Abstract Full Text Full Text PDF Scopus (1) Google Scholar have expressed, it has been a pleasure and a privilege to be trusted with the stewardship of the JMD in the presentation of excellent, innovative work from many thought-leaders in molecular pathology. It has been exciting and inspirational to communicate the defining recommendations and guidelines produced by the AMP expert workgroups. Readers will soon see some changes in the JMD as the staff, editors, and editorial board adapt the journal content to serve the emerging needs and scope of molecular pathologists' roles in delivering effective laboratory diagnostics and consultative support for physicians and other medical professionals." @default.
• W2980348913 created "2019-10-25" @default.
• W2980348913 creator A5032078333 @default.
• W2980348913 date "2019-11-01" @default.
• W2980348913 modified "2023-09-27" @default.
• W2980348913 title "The Journal of Molecular Diagnostics" @default.
• W2980348913 cites W1499222553 @default.
• W2980348913 cites W1521877785 @default.
• W2980348913 cites W1533032912 @default.
• W2980348913 cites W1533146179 @default.
• W2980348913 cites W1540968689 @default.
• W2980348913 cites W1561730525 @default.
• W2980348913 cites W1573917911 @default.
• W2980348913 cites W1574587481 @default.
• W2980348913 cites W1582369285 @default.
• W2980348913 cites W1585245493 @default.
• W2980348913 cites W1591517906 @default.
• W2980348913 cites W159357681 @default.
• W2980348913 cites W1600512601 @default.
• W2980348913 cites W165627435 @default.
• W2980348913 cites W1715726021 @default.
• W2980348913 cites W1812175583 @default.
• W2980348913 cites W18338672 @default.
• W2980348913 cites W1861083333 @default.
• W2980348913 cites W1934727085 @default.
• W2980348913 cites W1967678790 @default.
• W2980348913 cites W1976696799 @default.
• W2980348913 cites W1978236936 @default.
• W2980348913 cites W1983151271 @default.
• W2980348913 cites W1983542072 @default.
• W2980348913 cites W1989750162 @default.
• W2980348913 cites W1995894022 @default.
• W2980348913 cites W2007627461 @default.
• W2980348913 cites W2030469679 @default.
• W2980348913 cites W2032465462 @default.
• W2980348913 cites W2058441145 @default.
• W2980348913 cites W206316135 @default.
• W2980348913 cites W2079957251 @default.
• W2980348913 cites W2087098918 @default.
• W2980348913 cites W2104275147 @default.
• W2980348913 cites W2108427754 @default.
• W2980348913 cites W2108946660 @default.
• W2980348913 cites W2119743181 @default.
• W2980348913 cites W2126629202 @default.
• W2980348913 cites W2137411006 @default.
• W2980348913 cites W2141272033 @default.
• W2980348913 cites W2159853882 @default.
• W2980348913 cites W2163195607 @default.
• W2980348913 cites W2166068096 @default.
• W2980348913 cites W2167049728 @default.
• W2980348913 cites W2167628230 @default.
• W2980348913 cites W2169189616 @default.
• W2980348913 cites W2178874084 @default.
• W2980348913 cites W2212818516 @default.
• W2980348913 cites W2224756497 @default.
• W2980348913 cites W2229116738 @default.
• W2980348913 cites W2337675813 @default.
• W2980348913 cites W2347165597 @default.
• W2980348913 cites W2514874642 @default.
• W2980348913 cites W2518206830 @default.
• W2980348913 cites W2520218725 @default.
• W2980348913 cites W2534341018 @default.
• W2980348913 cites W2551506973 @default.
• W2980348913 cites W2566723262 @default.
• W2980348913 cites W2586443587 @default.
• W2980348913 cites W2595303879 @default.
• W2980348913 cites W2595388297 @default.
• W2980348913 cites W2603352569 @default.
• W2980348913 cites W2612470463 @default.
• W2980348913 cites W2769420359 @default.
• W2980348913 cites W2784623697 @default.
• W2980348913 cites W2789160819 @default.
• W2980348913 cites W2802476296 @default.
• W2980348913 cites W2802790507 @default.
• W2980348913 cites W2811483136 @default.
• W2980348913 cites W2888686509 @default.
• W2980348913 cites W2903946098 @default.
• W2980348913 cites W2906913602 @default.
• W2980348913 cites W2914835801 @default.
• W2980348913 cites W2944515601 @default.
• W2980348913 cites W2944614120 @default.
• W2980348913 cites W2981001869 @default.
• W2980348913 cites W2981035718 @default.
• W2980348913 cites W303319180 @default.
• W2980348913 cites W31576990 @default.
• W2980348913 cites W342668047 @default.
• W2980348913 cites W35645074 @default.
• W2980348913 cites W573764684 @default.
• W2980348913 cites W78554930 @default.
• W2980348913 doi "https://doi.org/10.1016/j.jmoldx.2019.09.001" @default.
• W2980348913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31635797" @default.
• W2980348913 hasPublicationYear "2019" @default.
• W2980348913 type Work @default.
• W2980348913 sameAs 2980348913 @default.
• W2980348913 citedByCount "1" @default.
• W2980348913 countsByYear W29803489132019 @default.
• W2980348913 crossrefType "journal-article" @default.
• W2980348913 hasAuthorship W2980348913A5032078333 @default.

• next